David Sidransky
Impact in
- Otorhinolaryngology top 0.02%
- Head and Neck Cancer Studies
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
Papers in
- Cancer Research 128
- Cancer Genomics and Diagnostics 85
- Oncology 173
- Cancer-related Molecular Pathways 107
- Co-authors
- Bert Vogelstein (13 shared papers)Monica C. Hollstein (3 shared papers)Curtis C. Harris (2 shared papers)Wayne M. Koch (86 shared papers)James Gordon Herman (19 shared papers)Joseph A. Califano (103 shared papers)William H. Westra (49 shared papers)Jin Jen (41 shared papers)
- Journals
- International Journal of Cancer (36 papers)Clinical Cancer Research (34 papers)Cancer Research (28 papers)Oncogene (19 papers)PLoS ONE (17 papers)
- Partner nations
- United StatesIndiaItaly
In The Last Decade
David Sidransky
602 papers receiving 77.7k citations
David Sidransky's Hit Papers
Peers
Comparison fields: 5 of 200
- Otorhinolaryngology 5.8k
- Cancer Research 16.9k
- Oncology 26.4k
- Pathology and Forensic Medicine 10.5k
- Molecular Biology 41.6k
Countries citing papers authored by David Sidransky
This map shows the geographic impact of David Sidransky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sidransky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sidransky more than expected).
Fields of papers citing papers by David Sidransky
This network shows the impact of papers produced by David Sidransky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sidransky. The network helps show where David Sidransky may publish in the future.
Co-authors
The 25 scholars most cited alongside David Sidransky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 609 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | p53 Mutations in Human Cancers Hit paper breakdown → | 1991 | 7030 |
| 2 | A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Hit paper breakdown → | 1998 | 3582 |
| 3 | Participation of p53 protein in the cellular response to DNA damage. Hit paper breakdown → | 1991 | 3369 |
| 4 | 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Hit paper breakdown → | 1995 | 1743 |
| 5 | Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 Hit paper breakdown → | 2011 | 1463 |
| 6 | Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Hit paper breakdown → | 1995 | 1196 |
| 7 | Genetic progression model for head and neck cancer: implications for field cancerization. Hit paper breakdown → | 1996 | 1150 |
| 8 | Head and Neck Cancer Hit paper breakdown → | 2001 | 1100 |
| 9 | Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer Hit paper breakdown → | 2006 | 916 |
| 10 | BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer Hit paper breakdown → | 2005 | 846 |
| 11 | Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Hit paper breakdown → | 1999 | 805 |
| 12 | Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer Hit paper breakdown → | 2013 | 791 |
| 13 | Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples Hit paper breakdown → | 1991 | 783 |
| 14 | 2000 | 723 | |
| 15 | Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma Hit paper breakdown → | 2003 | 723 |
| 16 | TP53 Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck Hit paper breakdown → | 2007 | 663 |
| 17 | Molecular Assessment of Histopathological Staging in Squamous-Cell Carcinoma of the Head and Neck Hit paper breakdown → | 1995 | 639 |
| 18 | Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal Tumors Hit paper breakdown → | 1992 | 613 |
| 19 | Clonal expansion of p53 mutant cells is associated with brain tumour progression Hit paper breakdown → | 1992 | 612 |
| 20 | 1998 | 603 |
About David Sidransky
David Sidransky is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Otorhinolaryngology, having authored 609 papers that have together received 80.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (131 papers), Cancer-related Molecular Pathways (107 papers), RNA modifications and cancer (98 papers), Cancer Genomics and Diagnostics (85 papers), Genetic factors in colorectal cancer (73 papers), Cancer-related gene regulation (72 papers), Head and Neck Cancer Studies (47 papers) and Mitochondrial Function and Pathology (34 papers). The work is most often cited by research in Otorhinolaryngology (5.8k citations), Cancer Research (16.9k citations), Oncology (26.4k citations), Pathology and Forensic Medicine (10.5k citations) and Molecular Biology (41.6k citations). David Sidransky has collaborated with scholars based in United States, India and Italy. Frequent co-authors include Bert Vogelstein, Monica C. Hollstein, Curtis C. Harris, Wayne M. Koch, James Gordon Herman, Joseph A. Califano, William H. Westra, Jin Jen, Stephen B. Baylin and Mohammad Obaidul Hoque. Their work appears in journals such as International Journal of Cancer, Clinical Cancer Research, Cancer Research, Oncogene and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.